[A multicenter randomized prospective study of concurrent chemoradiation with 60 Gy versus 50 Gy for inoperable esophageal squamous cell carcinoma].Yuanji Xu, M Chen, W W Wang et al.|PubMed|2020Cited by 8
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355)Xinyi Liu, Wenbin Shen, Jingyuan Wen et al.|Frontiers in Immunology|2025Cited by 3